Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4408)
All Articles published online
|
Publishing Process of This Article
|
Nov 14, 2021 (publication date) through May 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hsieh YY, Tung SY, Pan HY, Chang TS, Wei KL, Chen WM, Deng YF, Lu CK, Lai YH, Wu CS, Li C. Fusobacterium nucleatum colonization is associated with decreased survival of helicobacter pylori-positive gastric cancer patients. World J Gastroenterol 2021; 27(42): 7311-7323 [PMID: 34876791 DOI: 10.3748/wjg.v27.i42.7311] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v27/i42/7311.htm |
| Number | Citing Articles |
| 1 |
Yujia Ke, Cheng Tan, Junhai Zhen, Weiguo Dong. Global status and trends of gastric cancer and gastric microbiota research: a bibliometric analysis. Frontiers in Microbiology 2024; 15 doi: 10.3389/fmicb.2024.1341012
|
| 2 |
Pauline Raoul, Valeria Maccauro, Marco Cintoni, Emidio Scarpellini, Gianluca Ianiro, Antonio Gasbarrini, Maria Cristina Mele, Emanuele Rinninella. Microbiota–Gastric Cancer Interactions and the Potential Influence of Nutritional Therapies. International Journal of Molecular Sciences 2024; 25(3): 1679 doi: 10.3390/ijms25031679
|
| 3 |
Luigi Santacroce, Skender Topi, Lucrezia Bottalico, Ioannis Alexandros Charitos, Emilio Jirillo. Current Knowledge about Gastric Microbiota with Special Emphasis on Helicobacter pylori-Related Gastric Conditions. Current Issues in Molecular Biology 2024; 46(5): 4991 doi: 10.3390/cimb46050299
|
| 4 |
Xiangkun Meng, Gang Ma, Xu Zhang, Hua Yin, Yu Miao, Fang He.
Extracellular vesicles from
Fusobacterium nucleatum
: roles in the malignant phenotypes of gastric cancer
. Cell Cycle 2024; 23(3): 294 doi: 10.1080/15384101.2024.2324587
|
| 5 |
Pauline Raoul, Valeria De Gaetano, Gianmario Sciaraffia, Ginevra Ormea, Marco Cintoni, Carmelo Pozzo, Antonia Strippoli, Antonio Gasbarrini, Maria Cristina Mele, Emanuele Rinninella. Gastric Cancer, Immunotherapy, and Nutrition: The Role of Microbiota. Pathogens 2024; 13(5): 357 doi: 10.3390/pathogens13050357
|
| 6 |
Zhenzhen Chen, Leaf Huang. Fusobacterium nucleatum carcinogenesis and drug delivery interventions. Advanced Drug Delivery Reviews 2024; 209: 115319 doi: 10.1016/j.addr.2024.115319
|
| 7 |
Tanjin Tamanna, Md. Shahedur Rahman.
Leveraging immunoinformatics for developing a multi-epitope subunit vaccine against
Helicobacter pylori
and
Fusobacterium nucleatum
. Journal of Biomolecular Structure and Dynamics 2023; : 1 doi: 10.1080/07391102.2023.2292295
|
| 8 |
Yung-Yu Hsieh, Wen-Lin Kuo, Wan-Ting Hsu, Shui-Yi Tung, Chin Li. Fusobacterium Nucleatum-Induced Tumor Mutation Burden Predicts Poor Survival of Gastric Cancer Patients. Cancers 2022; 15(1): 269 doi: 10.3390/cancers15010269
|
| 9 |
Wen-Dan Chen, Xin Zhang, Meng-Jiao Zhang, Ya-Ping Zhang, Zi-Qi Shang, Yi-Wei Xin, Yi Zhang. Salivary <i>Fusobacterium nucleatum</i> serves as a potential diagnostic biomarker for gastric cancer. World Journal of Gastroenterology 2022; 28(30): 4120-4132 doi: 10.3748/wjg.v28.i30.4120
|
| 10 |
Yue Lai, Jun Mi, Qiang Feng. Fusobacterium nucleatum and Malignant Tumors of the Digestive Tract: A Mechanistic Overview. Bioengineering 2022; 9(7): 285 doi: 10.3390/bioengineering9070285
|
| 11 |
Xiulin Zhang, Ke Zhang, Linlin Yan, Pengfei Wang, Fan Zhao, Shoukui Hu. The role of toll‐like receptors in immune tolerance induced by Helicobacter pylori infection. Helicobacter 2023; 28(6) doi: 10.1111/hel.13020
|
| 12 |
Oulan Liao, Guanshui Ye, Qin Du, Jun Ye. Gastric microbiota in gastric cancer and precancerous stages: Mechanisms of carcinogenesis and clinical value. Helicobacter 2023; 28(3) doi: 10.1111/hel.12964
|
| 13 |
Marek Majewski, Paulina Mertowska, Sebastian Mertowski, Konrad Smolak, Ewelina Grywalska, Kamil Torres. Microbiota and the Immune System—Actors in the Gastric Cancer Story. Cancers 2022; 14(15): 3832 doi: 10.3390/cancers14153832
|
| 14 |
Jing Lei, Feng Xu, Chao Deng, Xubiao Nie, Li Zhong, Zhixuan Wu, Juan Li, Xiaoling Wu, Song He, Yongyu Chen. Fusobacterium nucleatum promotes the early occurrence of esophageal cancer through upregulation of IL‐32/PRTN3 expression. Cancer Science 2023; 114(6): 2414 doi: 10.1111/cas.15787
|
| 15 |
Zhiyi Liu, Dachuan Zhang, Siyu Chen. Unveiling the gastric microbiota: implications for gastric carcinogenesis, immune responses, and clinical prospects. Journal of Experimental & Clinical Cancer Research 2024; 43(1) doi: 10.1186/s13046-024-03034-7
|
| 16 |
Emilie Bessède, Francis Mégraud. Microbiota and gastric cancer. Seminars in Cancer Biology 2022; 86: 11 doi: 10.1016/j.semcancer.2022.05.001
|
| 17 |
Sally Ali Tawfik, Marwa Azab, Mohammed Ramadan, Sarah Shabayek, Ali Abdellah, Sultan S. Al Thagfan, Mohammed Salah. The Eradication of Helicobacter pylori Was Significantly Associated with Compositional Patterns of Orointestinal Axis Microbiota. Pathogens 2023; 12(6): 832 doi: 10.3390/pathogens12060832
|
| 18 |
Baptiste Oosterlinck, Hannah Ceuleers, Wout Arras, Joris G. De Man, Karen Geboes, Heiko De Schepper, Marc Peeters, Sarah Lebeer, Jurgita Skieceviciene, Georgina L. Hold, Juozas Kupcinskas, Alexander Link, Benedicte Y. De Winter, Annemieke Smet. Mucin-microbiome signatures shape the tumor microenvironment in gastric cancer. Microbiome 2023; 11(1) doi: 10.1186/s40168-023-01534-w
|
| 19 |
Chun Ye, Xiao Liu, Zilun Liu, Chuxuan Pan, Xiaowei Zhang, Zhanyi Zhao, Haitao Sun. Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance. Cancer Biology & Therapy 2024; 25(1) doi: 10.1080/15384047.2024.2306676
|
| 20 |
Jiwei Sun, Qingming Tang, Shaoling Yu, Mengru Xie, Wenhao Zheng, Guangjin Chen, Ying Yin, Xiaofei Huang, Keqi Wo, Haoqi Lei, Junyuan Zhang, Qian Wan, Lili Chen. F. nucleatum facilitates oral squamous cell carcinoma progression via GLUT1-driven lactate production. eBioMedicine 2023; 88: 104444 doi: 10.1016/j.ebiom.2023.104444
|
| 21 |
Jia-Hao Dai, Xi-Rong Tan, Han Qiao, Na Liu. Emerging clinical relevance of microbiome in cancer: promising biomarkers and therapeutic targets. Protein & Cell 2024; 15(4): 239 doi: 10.1093/procel/pwad052
|
| 22 |
Zhixing He, Wei Tian, Qichun Wei, Jing Xu. Involvement of Fusobacterium nucleatum in malignancies except for colorectal cancer: A literature review. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.968649
|
| 23 |
Ruiyu Wang, Shu Huang, Peiling Gan, Xiao Pan, Ping Wang, Xiaolin Zhong, Muhan Lü, Xian Zhou, Xiaowei Tang. States and hotspots in Helicobacter pylori research from 2002 to 2021: A bibliometric analysis. Helicobacter 2023; 28(4) doi: 10.1111/hel.12986
|
| 24 |
K.A. Kaiumov, A.V. Lyamin, A.V. Zhestkov, I.V. Bazhutova. Fusobacterium nucleatum: from a classic periodontal pathogen to a complete participant of carcinogenesis. Clinical Microbiology and Antimicrobial Chemotherapy 2023; 25(1): 13 doi: 10.36488/cmac.2023.1.13-18
|
| 25 |
Changzhen Lei, Yitian Xu, Shaopeng Zhang, Chen Huang, Jing Qin. The role of microbiota in gastric cancer: A comprehensive review. Helicobacter 2024; 29(2) doi: 10.1111/hel.13071
|